King Mohammed VI chaired this Monday, July 5, the launching and signing ceremony of conventions relating to the project of manufacture and syringe in Morocco of the anti-Covid vaccine and other vaccines.
The result of a public-private partnership, the project aims to start in the short term with a production capacity of 5 million doses of anti-Covid19 vaccine per month, before gradually increasing this capacity in the medium term. It will mobilize a global investment of around $ 500 million.
In doing so, the Kingdom is taking a big step towards vaccine sovereignty, so important in these times of pandemic, marked in particular by a global vaccine race, a race where the less strong are the last served.
King Mohammed VI, who has been at the forefront since the appearance of the first case of Covid-19 in the country on March 2, 2020, has taken all the decisions, and been at the origin of all the initiatives allowing Morocco and Moroccans to experience this ordeal in the best possible conditions.
From financial aid, to support for different sectors, through the creation of the Mohammed VI Fund for investment and free vaccination for all, the Sovereign comes to crown this vision by the conclusion of an agreement which will allow the Kingdom to ” integrate the closed circle of producers, and thus get rid of dependence on vaccine suppliers, not always lenient in times of crisis where the watchword is “me first”.
This vision is not limited only to vaccination against Covid-19, an operation that Morocco is leading with full force and which has made it a continental champion. No, it goes beyond to anticipate future crises, and needs that will inevitably arise, and will thus be able to find satisfaction, within the framework of health self-sufficiency, of capital importance.
Secure urgent vaccine needs
This sovereignty will also provide, according to the Minister of Health, Khalid Ait Taleb, “the appropriate response to the risks of the appearance of new viral variants or new epidemics”.
Speaking to the Sovereign during the signing ceremony, Ait Taleb did not fail to stress that this step, added to a new national pharmaceutical policy and in alignment with the new development model of the Kingdom, “should guarantee everyone Moroccan citizens have geographically and financially equitable access to quality medicines and health products, while supporting the local manufacture of medicines within the framework of public-private partnerships ”.
“This vaccine sovereignty is part of a roadmap, with a progressive and accelerated approach, to secure urgent needs in Covid-19 vaccines in the short term, for the production of vaccines for the national medium-term immunization plan and build a continental platform for long-term research and development, ”he added.
For his part, the CEO of the Sinopharm Group, Liu Jengzhen, who spoke at a distance from Beijing, estimated that the Moroccan-Chinese project will provide solid support for the prevention and control of the pandemic in Morocco.
This project is of great importance for both Morocco and China in the fight against the Covid-19 pandemic, just as it will participate in the prevention and control of the pandemic at the global level, he said. said.
According to the boss of Sinopharm, the project will also strengthen the health resilience of the peoples of the Kingdom and Africa, as it will make an important contribution to the consolidation of the Sino-Moroccan friendship.
The Kingdom of Morocco and China are fighting together against the Covid-19 pandemic, and the talks between the Heads of State of the two countries made it possible to reach a series of consensus on the joint fight against the pandemic and the deepening of economic and trade cooperation, argued Liu Jengzhen.
He also observed that the group has achieved good cooperation with the government and Moroccan institutions in terms of research and development of the vaccine against Covid-19, recalling in that the Kingdom has provided Sinopharm with solid aid and a valuable support in clinical trials abroad.